As of 10:30 AM on the 4th, Celltrion Healthcare is trading at 150,500 KRW, down 7.67% from the previous day. This represents a 14.92% decline compared to December 21. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

Over the past five days, individual investors have net sold 525,470 shares, while foreigners and institutions have net sold 79,242 shares and net bought 533,214 shares, respectively.



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing